CY1902A - Macrocyclic aminophosphonic acid complexes their preparation formulations and use - Google Patents
Macrocyclic aminophosphonic acid complexes their preparation formulations and useInfo
- Publication number
- CY1902A CY1902A CY190289A CY190289A CY1902A CY 1902 A CY1902 A CY 1902A CY 190289 A CY190289 A CY 190289A CY 190289 A CY190289 A CY 190289A CY 1902 A CY1902 A CY 1902A
- Authority
- CY
- Cyprus
- Prior art keywords
- acid complexes
- aminophosphonic acid
- preparation formulations
- macrocyclic aminophosphonic
- macrocyclic
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- PTMHPRAIXMAOOB-UHFFFAOYSA-N phosphoramidic acid Chemical class NP(O)(O)=O PTMHPRAIXMAOOB-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/284,876 US5059412A (en) | 1984-06-04 | 1988-12-19 | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
PCT/US1989/005782 WO1990006776A1 (en) | 1988-12-19 | 1989-12-15 | Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1902A true CY1902A (en) | 1989-12-15 |
Family
ID=23091854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY190289A CY1902A (en) | 1988-12-19 | 1989-12-15 | Macrocyclic aminophosphonic acid complexes their preparation formulations and use |
Country Status (26)
Country | Link |
---|---|
US (1) | US5059412A (de) |
EP (2) | EP0408701B1 (de) |
JP (1) | JP2515929B2 (de) |
KR (1) | KR0178966B1 (de) |
CN (1) | CN1025983C (de) |
AR (1) | AR248140A1 (de) |
AT (1) | ATE112689T1 (de) |
AU (3) | AU639899B2 (de) |
BR (1) | BR8907255A (de) |
CA (1) | CA2005880C (de) |
CY (1) | CY1902A (de) |
DE (1) | DE68918852T2 (de) |
DK (1) | DK175479B1 (de) |
ES (1) | ES2061010T3 (de) |
FI (1) | FI101857B (de) |
HK (1) | HK146795A (de) |
HU (1) | HU207454B (de) |
IE (2) | IE940833L (de) |
IL (1) | IL92784A (de) |
MX (1) | MX18786A (de) |
NO (1) | NO180434C (de) |
NZ (1) | NZ231818A (de) |
PT (1) | PT92619B (de) |
SA (1) | SA91120234B1 (de) |
WO (1) | WO1990006776A1 (de) |
ZA (1) | ZA899734B (de) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
US5645818A (en) * | 1989-03-24 | 1997-07-08 | Guerbet S.A. | Diagnostic compositions comprising a complex formed by a nitrogenous macrocyclic ligand with metal ions |
DE4009119A1 (de) * | 1990-03-19 | 1991-09-26 | Schering Ag | 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
WO1991016075A1 (en) * | 1990-04-20 | 1991-10-31 | Australian Nuclear Science & Technology Organisation | Bone marrow treatments |
MC2260A1 (fr) * | 1990-06-18 | 1993-04-26 | Dow Chemical Co | Formulations de produits radiopharmaceutiques,leur methode d'administration et leur procede de preparation |
BR9102490A (pt) * | 1990-06-18 | 1992-01-21 | Dow Chemical Co | Metodo para uso diagnostico na formacao de imagens e composicao |
DE4035760A1 (de) * | 1990-11-08 | 1992-05-14 | Schering Ag | Mono-n-substituierte 1,4,7,10-tetraazacyclododecan-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
US5320829A (en) * | 1991-12-10 | 1994-06-14 | The Dow Chemical Company | Oral compositions for inhibiting plaque formation |
US5739294A (en) * | 1991-12-10 | 1998-04-14 | The Dow Chemical Company | Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents |
US5428139A (en) * | 1991-12-10 | 1995-06-27 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acid complexes for use as radiopharmaceuticals |
US5874573A (en) * | 1995-06-26 | 1999-02-23 | Concat, Inc. | Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy |
US5834456A (en) * | 1996-02-23 | 1998-11-10 | The Dow Chemical Company | Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents |
US6005083A (en) | 1997-03-28 | 1999-12-21 | Neorx Corporation | Bridged aromatic substituted amine ligands with donor atoms |
AU5871000A (en) * | 1999-06-11 | 2001-01-02 | Paul G. Abrams | High dose radionuclide complexes for bone marrow suppression |
US7094885B2 (en) * | 1999-07-11 | 2006-08-22 | Neorx Corporation | Skeletal-targeted radiation to treat bone-associated pathologies |
US6565828B2 (en) | 2000-04-07 | 2003-05-20 | Bristol-Myers Squibb Company | Macrocyclic chelants for metallopharmaceuticals |
CA2434302A1 (en) * | 2001-01-08 | 2002-08-15 | Neorx Corporation | Therapeutic and diagnostic compounds, compositions, and methods |
WO2002055112A2 (en) * | 2001-01-09 | 2002-07-18 | Bristol Myers Squibb Co | Polypodal chelants for metallopharmaceuticals |
EP1458416A1 (de) | 2001-12-13 | 2004-09-22 | Dow Global Technologies Inc. | Behandlung von osteomyelitis mit einer radiopharmazeutischen zusammensetzung |
US20030228256A1 (en) * | 2002-06-11 | 2003-12-11 | Inverardi Luca A. | Methods of achieving transplantation tolerance through radioablation of hemolymphopoietic cell populations |
WO2007008232A2 (en) | 2004-09-03 | 2007-01-18 | Board Of Regents, The University Of Texas System | Locoregional internal radionuclide ablation of abnormal tissues. |
WO2011149844A1 (en) * | 2010-05-24 | 2011-12-01 | Iso Therapeutics Group Llc | Delivery of high dose therapeutic radioisotopes to bone |
HUE062439T2 (hu) | 2013-10-07 | 2023-11-28 | Igl Pharma Inc | Eljárás nagy tisztaságú terápiás csont szerek elõállítására |
WO2016191413A1 (en) | 2015-05-25 | 2016-12-01 | Iso Therapeutics Group, Llc | Dotmp kit formulations for radioisotopes |
US11369700B2 (en) | 2015-05-25 | 2022-06-28 | IGL Pharma Inc. | DOTMP kit formulations for radioisotopes |
BR112019006066A2 (pt) | 2016-09-27 | 2019-06-18 | Bayer Pharma AG | método para produzir a forma cristalina de modificação a de calcobutrol |
CA3052973C (en) | 2017-02-08 | 2024-02-06 | Igl Pharma, Inc. | Method of use for therapeutic bone agents |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3965254A (en) * | 1973-05-23 | 1976-06-22 | The Procter & Gamble Company | Compositions for the treatment of calcific tumors |
US4017595A (en) * | 1975-08-28 | 1977-04-12 | Research Corporation | Bone-seeking indium-113m or indium-111 organic phosphonate complexes |
CA1078731A (en) * | 1976-12-16 | 1980-06-03 | Charles E. Frosst And Co. | Skeletal imaging kit utilizing triethylene tetramine hexa (methylene phosphonic acid) |
US4957939A (en) * | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
SU1098937A1 (ru) * | 1983-03-25 | 1984-06-23 | Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова | 1,4,7,10-Тетра/диоксифосфорилметил/-1,4,7,10-тетраазациклододекан в качестве комплексона дл св зывани катионов меди /п/,кобальта /п/,кадми /п/,свинца /п/ и лантана /ш/ |
US5064633A (en) * | 1984-06-04 | 1991-11-12 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes, their formulations and use |
US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
AU563671B2 (en) * | 1984-06-04 | 1987-07-16 | Dow Chemical Company, The | Organic amine phosphonic acid complexes |
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
FR2614020B1 (fr) * | 1987-04-14 | 1989-07-28 | Guerbet Sa | Nouveaux ligands cycliques azotes, complexes metalliques formes par ces ligands, compositions de diagnostic contenant ces complexes et procede de preparation des ligands. |
US4853209A (en) * | 1987-05-18 | 1989-08-01 | The Dow Chemical Company | Bone marrow suppressing agents |
US4882142A (en) * | 1988-12-19 | 1989-11-21 | The Dow Chemical Company | Bone marrow suppressing agents |
US4976950A (en) * | 1988-12-19 | 1990-12-11 | The Dow Chemical Company | Bone marrow suppressing agents |
-
1988
- 1988-12-19 US US07/284,876 patent/US5059412A/en not_active Expired - Lifetime
-
1989
- 1989-12-15 AU AU48282/90A patent/AU639899B2/en not_active Expired
- 1989-12-15 HU HU901163A patent/HU207454B/hu not_active IP Right Cessation
- 1989-12-15 BR BR898907255A patent/BR8907255A/pt not_active Application Discontinuation
- 1989-12-15 EP EP90901464A patent/EP0408701B1/de not_active Expired - Lifetime
- 1989-12-15 WO PCT/US1989/005782 patent/WO1990006776A1/en active IP Right Grant
- 1989-12-15 JP JP2501907A patent/JP2515929B2/ja not_active Expired - Fee Related
- 1989-12-15 ES ES90901464T patent/ES2061010T3/es not_active Expired - Lifetime
- 1989-12-15 DE DE68918852T patent/DE68918852T2/de not_active Expired - Lifetime
- 1989-12-15 AT AT90901464T patent/ATE112689T1/de not_active IP Right Cessation
- 1989-12-15 KR KR1019900701800A patent/KR0178966B1/ko not_active IP Right Cessation
- 1989-12-15 CY CY190289A patent/CY1902A/xx unknown
- 1989-12-18 IE IE940833A patent/IE940833L/xx unknown
- 1989-12-18 IL IL9278489A patent/IL92784A/en unknown
- 1989-12-18 CA CA002005880A patent/CA2005880C/en not_active Expired - Lifetime
- 1989-12-18 IE IE406389A patent/IE66391B1/en not_active IP Right Cessation
- 1989-12-18 NZ NZ231818A patent/NZ231818A/en unknown
- 1989-12-19 ZA ZA899734A patent/ZA899734B/xx unknown
- 1989-12-19 AR AR89315722A patent/AR248140A1/es active
- 1989-12-19 AU AU47009/89A patent/AU4700989A/en not_active Abandoned
- 1989-12-19 EP EP19890313308 patent/EP0375376A3/de not_active Withdrawn
- 1989-12-19 MX MX1878689A patent/MX18786A/es unknown
- 1989-12-19 PT PT92619A patent/PT92619B/pt not_active IP Right Cessation
- 1989-12-19 CN CN89109819A patent/CN1025983C/zh not_active Expired - Lifetime
-
1990
- 1990-08-16 DK DK199001959A patent/DK175479B1/da not_active IP Right Cessation
- 1990-08-17 NO NO903632A patent/NO180434C/no not_active IP Right Cessation
- 1990-08-17 FI FI904084A patent/FI101857B/fi not_active IP Right Cessation
-
1991
- 1991-11-20 SA SA91120234A patent/SA91120234B1/ar unknown
-
1993
- 1993-11-12 AU AU50685/93A patent/AU657641B2/en not_active Expired
-
1995
- 1995-09-14 HK HK146795A patent/HK146795A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK146795A (en) | Macrocyclic aminophosphonic acid complexes their preparation formulations and use | |
CY2050B1 (en) | 7-Piperazinyl-or 7-morpholino-4-oxo-quinoline-3-carboxylic acid derivatives their preparation and their use as antimicrobial agents | |
NZ219274A (en) | Indolizine derivatives and pharmaceutical compositions | |
EP0236120A3 (en) | Mixed phosphoric diesters, preparation thereof, and use thereof as antiinflammatory agents | |
GB8828477D0 (en) | Medical aerosol formulations | |
IL88814A0 (en) | Soluble polyimidesiloxanes,their preparation and use | |
EP0328027A3 (en) | Novel soluble polyimidesiloxanes and methods for their preparation and use | |
IL90158A0 (en) | Perfluoropolyether derivatives and their preparation | |
HK125293A (en) | Oral preparations | |
IL85529A (en) | Biphenylalkenyl-substituted tetrazole derivatives and their preparation | |
JPS6454032A (en) | Polydisilacyclobutasilazane and its preparation and use | |
GR860075B (en) | Compositions their preparation and use | |
GB2157684B (en) | Triazolopyrimidines their preparation and use in medicine | |
GB8824508D0 (en) | Structure & connector for use in same | |
IL72862A0 (en) | Aminocyclopentanes and their preparation and pharmaceutical formulations | |
ZA893479B (en) | 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid derivatives and their preparation | |
GR890300157T1 (en) | Griseolic acid monoesters, their preparation and use | |
IL87030A0 (en) | Bicyclo-octanes and nonanes and compositions | |
HK1003571A1 (en) | Alkenyltetrazole derivatives their preparation and use | |
EP0312838A3 (en) | Basic azodyes, their preparation and their use | |
GB8924207D0 (en) | Formulations | |
GB8802391D0 (en) | Medicinal formulations | |
IL85664A0 (en) | Dicyanoethylaryl derivatives and their preparation | |
GB2224453B (en) | The tooth fairys magic kingdom toy | |
CS275022B2 (en) | Powdered dietetic preparation |